Skip To Main Content
Karina Vianna on Muck Rack

Karina Vianna

As seen in: Nature, ONCOLOGY journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Karina

Contact Karina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Karina Maia Vianna

|
By Karina Vianna
| ONCOLOGY journal Verified
Articles by Karina Maia Vianna 95 monarchE: Subgroup Analysis of Adjuvant Abemaciclib + Endocrine Therapy for HR+/HER2−, High-Risk, Early Breast Cancer by Nodal Status ByJavier Cortés, MD,Stephen R.D. Johnston,Miguel Martin, MD, PhD,Sara M. Tolaney, MD, MPH,Matthew P. Goetz, MD,Hope S.
Open in Who Shared View Duplicates (5) Issue with article?

Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial - Nature Medicine

|
By Gerhardt Attard, Neeraj Agarwal, Julie Graff, Shahneen Sandhu, Mustafa Özgüroğlu, Fei Shen, Karina Vianna
| Nature Verified
Abstract Inhibition of poly(ADP-ribose) polymerase (PARP) after relapse on hormone therapy is well established for patients with prostate cancer with homologous recombination repair (HRR) gene alterations, but resistance often develops.
Open in Who Shared Issue with article?
See all 2 articles